Parkinson's Disease Clinical Trials (Enrolling)
Microbiota Intervention to Change the Response of Parkinson's Disease (Micro-PD)
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Hannah McCarthy Potter, [email protected]
The Parkinson's Progression Markers Initiative (PPMI) 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Farah.Kausar, PhD, [email protected]
Parkinson Progression Marker Initiative Online (PPMI Online)
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: [email protected]
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Farah.Kausar, PhD, [email protected]
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Corinna Conroy, [email protected]
TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Jacque Perkins, [email protected]
PD GENEration: Mapping the Future of Parkinson's Disease
Principal Investigator: Jill Ostrem, MD
Study Contact: Eda Yilmaz, [email protected]
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Principal Investigator: Simon Little, MBBS, PhD
Study Contact: Elena Ubeda Matzilevich, [email protected]
Web-based Automated Imaging Differentiation of Parkinsonism
Principal Investigator: Jill Ostrem, MD
Study Contact: Eda Yilmaz, [email protected]
Advanced Magnetic Resonance Imaging for Deep Brain Stimulation Therapy
Principal Investigator: Melanie Morrison, PhD
Study Contact: Sarah Wang, PhD, [email protected]
Globus pallidus interna (GPi) deep brain stimulation (DBS) for Parkinson’s Disease (PD): Impact on sleep disorders
Principal Investigator: Rafael Zuzuarregui, MD
Study Contact: Allisun Wiltshire, [email protected]
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Principal Investigator: Marta San Luciano, MD, MS
Study Contact: Jennifer Zhu, [email protected] and Allisun Wiltshire, [email protected]
Subgaleal cortical recordings in patients with Parkinson's disease undergoing Deep Brain Stimulation Therapy
Principal Investigator: Philip Starr, MD, PhD
Study Contact: Stephanie Sandoval-Pistorius, [email protected]